[application] biopharmaceutical China Germany technology exchange Summit Forum

Sterility assurance and risk control in the process of drug production and inspection are the key to ensure the quality and safety of drugs, and are also the focus of attention of pharmaceutical enterprises and regulatory agencies In order to strengthen the communication between regulatory agencies and pharmaceutical enterprises, improve the level of aseptic assurance and quality control ability, China Pharmaceutical Enterprise Development Association, together with German pharmaceutical and laboratory equipment professional brand sartorius, will bring wonderful "biopharmaceutical Sino German technology exchange Summit Forum" to pharmaceutical colleagues on July 10 (Shanghai) and July 12 (Beijing), respectively This meeting will invite German experts from drug regulatory agencies, clinical research centers, pharmaceutical companies and sartorius to analyze new hot topics of drug quality control, and conduct in-depth exchanges and discussions on research progress of car-t cell therapy, new progress and implementation strategies of sterility testing, environmental monitoring and regulatory dynamics in clean areas, etc We sincerely invite you to join this technology event Time and place of meeting: Shanghai station; 9:00-17:00, July 10, 2019; banquet hall of Shanghai Boya Hotel; 699 Bibo Road, Pudong New Area, Shanghai (near Zhangjiang High Tech station of Metro Line 2); Beijing station; 9:00-17:00, July 12, 2019; Liangmahe Hotel, Beijing; Wandai hall; 8 Dongsanhuan North Road, Chaoyang District, Beijing (near Liangmahe station, Metro Line 10) Progress in clinical research of car-t cell therapy progress in clinical research of cell therapy validation of sterility test and routine sterility test interpretation of the updated contents of general principles 9205 guiding principles for microbiological monitoring and control of pharmaceutical clean laboratory in Chinese Pharmacopoeia 2020 edition data integrity of cedolis Cubis Tianping in GXP environment importance of water quality in downstream QC analysis Progress of laws and regulations on continuous monitoring of air microorganism in clean environment part speech by Li Zonghai, research leader of biotherapy group of State Key Laboratory of Shanghai Institute of oncology, Han Weidong professor of Molecular Immunology Research Office of Life Science Institute of PLA General Hospital, Du hongmenuo and Cao Xiaoyun, Commissioner of quality management department of Nord (China) Pharmaceutical Co., Ltd Attended by Frank getzmeyer, weighing product expert of saiduolis group laboratory, director of antibiotic Department of Tianjin Institute of drug testing, Michel van musschenbroek, product manager of global pure water system of saiduolis group, microbiological testing product expert of saiduolis group Quality management personnel, QC or QA personnel of drug manufacturing enterprises, and personnel engaged in drug production supervision Each unit is limited to 2 people The way to attend the meeting is free of charge, and lunch and tea break are provided Please take care of your own travel and accommodation Registration deadline: July 5, 2019 note: the number of participants is limited We will confirm with you whether the registration is successful within ten working days after receiving the registration information Scan QR code to register with Meeting contact Shelly Li sedolis China, marketing department